Cover Image
Market Research Report

Global Dermatology OTC Medications Market Insights, Forecast to 2025

Published by QYResearch Product code 924017
Published Content info 153 Pages
Delivery time: 2-3 business days
Price
Back to Top
Global Dermatology OTC Medications Market Insights, Forecast to 2025
Published: February 6, 2020 Content info: 153 Pages
Description

This report studies the global market size of Dermatology OTC Medications in key regions like North America, Europe, Asia Pacific, Central & South America and the Middle East & Africa, focuses on the consumption of Dermatology OTC Medications in these regions.

This research report categorizes the global Dermatology OTC Medications market by top players/brands, region, type and end user. This report also studies the global Dermatology OTC Medications market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

In 2018, the global Dermatology OTC Medications market size was increased to 11675 million US$ from 10343 million US$ in 2014, and it will reach 14530 million US$ in 2025, growing at CAGR of 3.25% between 2019 and 2025.

The objectives of this study are to define, segment, and project the size of the Dermatology OTC Medications market based on company, product type, end-user and key regions.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

  • Bayer
  • GSK
  • Teva
  • Johnson & Johnson
  • Novartis
  • Mylan
  • Sun Pharmaceutical
  • Aurobindo
  • Galderma
  • CR SANJIU
  • Dr. Reddy's
  • Lupin
  • Bausch Health
  • Cipla
  • Qilu Pharmaceutical
  • Almirall
  • Lingrui

Dermatology OTC Medications market size by type:

  • External Use
  • Oral p>Dermatology OTC Medications market size by Applications:
  • Hospital
  • Drug Store
  • Other

Dermatology OTC Medications market size by region:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • Southeast Asia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
    • Rest of Europe
  • Central & South America
    • Brazil
    • Argentina
    • Rest of Central & South America
  • Middle East & Africa
    • Africa
    • Middle East
Table of Contents

Table of Contents

1 Study Coverage

  • 1.1 Dermatology OTC Medications Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Manufacturers Covered
  • 1.4 Market by Type
    • 1.4.1 Global Dermatology OTC Medications Market Size Growth Rate by Type
    • 1.4.2 External Use
    • 1.4.3 Oral
  • 1.5 Market by Application
    • 1.5.1 Global Dermatology OTC Medications Market Size Growth Rate by Application
    • 1.5.2 Hospital
    • 1.5.3 Drug Store
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Dermatology OTC Medications Market Size
    • 2.1.1 Global Dermatology OTC Medications Revenue 2014-2025
    • 2.1.2 Global Dermatology OTC Medications Sales 2014-2025
  • 2.2 Dermatology OTC Medications Growth Rate by Region
    • 2.2.1 Global Dermatology OTC Medications Sales by Region
    • 2.2.2 Global Dermatology OTC Medications Revenue by Region

3 Breakdown Data by Manufacturer

  • 3.1 Dermatology OTC Medications Sales by Manufacturer
    • 3.1.1 Dermatology OTC Medications Sales by Manufacturer
    • 3.1.2 Dermatology OTC Medications Sales Market Share by Manufacturer
  • 3.2 Dermatology OTC Medications Revenue by Manufacturer
    • 3.2.1 Dermatology OTC Medications Revenue by Manufacturer (2018-2019)
    • 3.2.2 Dermatology OTC Medications Revenue Share by Manufacturer (2018-2019)
    • 3.2.3 Global Market Concentration Ratio (CR5 and HHI)
  • 3.3 Dermatology OTC Medications Price by Manufacturer
  • 3.4 Dermatology OTC Medications Manufacturing Base Distribution, Product Types
    • 3.4.1 Dermatology OTC Medications Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Dermatology OTC Medications Product Type
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type

  • 4.1 Global Dermatology OTC Medications Sales by Type
  • 4.2 Global Dermatology OTC Medications Revenue by Type
  • 4.3 Dermatology OTC Medications Price by Type

5 Breakdown Data by Application

  • 5.1 Overview
  • 5.2 Global Dermatology OTC Medications Breakdown Data by Application

6 North America

  • 6.1 North America Dermatology OTC Medications by Country
    • 6.1.1 North America Dermatology OTC Medications Sales by Country
    • 6.1.2 North America Dermatology OTC Medications Revenue by Country
    • 6.1.3 United States
    • 6.1.4 Canada
    • 6.1.5 Mexico
  • 6.2 North America Dermatology OTC Medications by Type
  • 6.3 North America Dermatology OTC Medications by Application

7 Europe

  • 7.1 Europe Dermatology OTC Medications by Country
    • 7.1.1 Europe Dermatology OTC Medications Sales by Country
    • 7.1.2 Europe Dermatology OTC Medications Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 UK
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Dermatology OTC Medications by Type
  • 7.3 Europe Dermatology OTC Medications by Application

8 Asia Pacific

  • 8.1 Asia Pacific Dermatology OTC Medications by Country
    • 8.1.1 Asia Pacific Dermatology OTC Medications Sales by Country
    • 8.1.2 Asia Pacific Dermatology OTC Medications Revenue by Country
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Southeast Asia
  • 8.2 Asia Pacific Dermatology OTC Medications by Type
  • 8.3 Asia Pacific Dermatology OTC Medications by Application

9 Central & South America

  • 9.1 Central & South America Dermatology OTC Medications by Country
    • 9.1.1 Central & South America Dermatology OTC Medications Sales by Country
    • 9.1.2 Central & South America Dermatology OTC Medications Revenue by Country
    • 9.1.3 Brazil
    • 9.1.4 Argentina
  • 9.2 Central & South America Dermatology OTC Medications by Type
  • 9.3 Central & South America Dermatology OTC Medications by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Dermatology OTC Medications by Country
    • 10.1.1 Middle East and Africa Dermatology OTC Medications Sales by Country
    • 10.1.2 Middle East and Africa Dermatology OTC Medications Revenue by Country
    • 10.1.3 Middle East
    • 10.1.4 Africa
  • 10.2 Middle East and Africa Dermatology OTC Medications by Type
  • 10.3 Middle East and Africa Dermatology OTC Medications by Application

11 Analysis of Dermatology OTC Medications Industry Key Manufacturers

  • 11.1 Bayer
    • 11.1.1 Company Profile
    • 11.1.2 Product Information
    • 11.1.3 Sales, Price and Revenue
  • 11.2 GSK
    • 11.2.1 Company Profile
    • 11.2.2 Product Information
    • 11.2.3 Sales, Price and Revenue
  • 11.3 Teva
    • 11.3.1 Company Profile
    • 11.3.2 Product Information
    • 11.3.3 Sales, Price and Revenue
  • 11.4 Johnson & Johnson
    • 11.4.1 Company Profile
    • 11.4.2 Product Information
    • 11.4.3 Sales, Price and Revenue
  • 11.5 Novartis
    • 11.5.1 Company Profile
    • 11.5.2 Product Information
    • 11.5.3 Sales, Price and Revenue
  • 11.6 Mylan
    • 11.6.1 Company Profile
    • 11.6.2 Product Information
    • 11.6.3 Sales, Price and Revenue
  • 11.7 Sun Pharmaceutical
    • 11.7.1 Company Profile
    • 11.7.2 Product Information
    • 11.7.3 Sales, Price and Revenue
  • 11.8 Aurobindo
    • 11.8.1 Company Profile
    • 11.8.2 Product Information
    • 11.8.3 Sales, Price and Revenue
  • 11.9 Galderma
    • 11.9.1 Company Profile
    • 11.9.2 Product Information
    • 11.9.3 Sales, Price and Revenue
  • 11.10 CR SANJIU
    • 11.10.1 Company Profile
    • 11.10.2 Product Information
    • 11.10.3 Sales, Price and Revenue
  • 11.11 Dr. Reddy's
    • 11.11.1 Company Profile
    • 11.11.2 Product Information
    • 11.11.3 Sales, Price and Revenue
  • 11.12 Lupin
    • 11.12.1 Company Profile
    • 11.12.2 Product Information
    • 11.12.3 Sales, Price and Revenue
  • 11.13 Bausch Health
    • 11.13.1 Company Profile
    • 11.13.2 Product Information
    • 11.13.3 Sales, Price and Revenue
  • 11.14 Cipla
    • 11.14.1 Company Profile
    • 11.14.2 Product Information
    • 11.14.3 Sales, Price and Revenue
  • 11.15 Qilu Pharmaceutical
    • 11.15.1 Company Profile
    • 11.15.2 Product Information
    • 11.15.3 Sales, Price and Revenue
  • 11.16 Almirall
    • 11.16.1 Company Profile
    • 11.16.2 Product Information
    • 11.16.3 Sales, Price and Revenue
  • 11.17 Lingrui
    • 11.17.1 Company Profile
    • 11.17.2 Product Information
    • 11.17.3 Sales, Price and Revenue

12 Future Forecast

  • 12.1 Dermatology OTC Medications Market Forecast by Region
    • 12.1.1 Global Dermatology OTC Medications Sales Forecast by Region 2020-2025
    • 12.1.2 Global Dermatology OTC Medications Revenue Forecast by Region 2020-2025
  • 12.2 Dermatology OTC Medications Market Forecast by Type
    • 12.2.1 Global Dermatology OTC Medications Sales Forecast by Type (2020-2025)
    • 12.2.2 Global Dermatology OTC Medications Revenue Forecast by Type (2020-2025)
  • 12.3 Dermatology OTC Medications Market Forecast by Application
  • 12.4 North America Dermatology OTC Medications Forecast
  • 12.5 Europe Dermatology OTC Medications Forecast
  • 12.6 Asia Pacific Dermatology OTC Medications Forecast
  • 12.7 Central & South America Dermatology OTC Medications Forecast
  • 12.8 Middle East and Africa Dermatology OTC Medications Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Trends
  • 13.3 Market Risks/Restraints
  • 13.4 Porter's Five Forces Analysis

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Dermatology OTC Medications Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

  • 16.1 Research Methodology
    • 16.1.1 Methodology/Research Approach
      • 16.1.1.1 Research Programs/Design
      • 16.1.1.2 Market Size Estimation
      • 16.1.1.3 Market Breakdown and Data Triangulation
    • 16.1.2 Data Source
      • 16.1.2.1 Secondary Sources
      • 16.1.2.2 Primary Sources
  • 16.2 Author Details
  • 16.3 Disclaimer

List of Tables and Figures

  • Figure Dermatology OTC Medications Product Picture
  • Table Dermatology OTC Medications Market Segments
  • Table Key Manufacturers of Dermatology OTC Medications Covered in 2018
  • Table Global Dermatology OTC Medications Market Size Growth Rate by Type (2020-2025) (M Unit) & (M USD)
  • Figure Global Dermatology OTC Medications Sales Market Share by Type in 2018
  • Figure Global Dermatology OTC Medications Sales Market Share by Type in 2025
  • Table Classification of Dermatology OTC Medications
  • Figure External Use Product Picture
  • Figure Oral Product Picture
  • Table Global Dermatology OTC Medications Market Size Growth Rate by Application (2020-2025) (M Unit)
  • Figure Global Dermatology OTC Medications Sales Market Share by Application in 2018
  • Table Applications of Dermatology OTC Medications
  • Figure Hospital
  • Figure Drug Store
  • Figure Dermatology OTC Medications Report Years Considered
  • Figure Global Dermatology OTC Medications Market Size 2014-2025 (M USD)
  • Figure Global Dermatology OTC Medications Sales 2014-2025 (M Unit)
  • Table Global Dermatology OTC Medications Market Size by Region 2014-2019 (M Unit) & (M USD)
  • Figure Global Dermatology OTC Medications Market Share by Regions 2018
  • Table Global Dermatology OTC Medications Sales by Region 2014-2019 (M Unit)
  • Table Global Dermatology OTC Medications Sales Market Share by Region 2014-2019
  • Figure Global Dermatology OTC Medications Sales Market Share by Region 2014-2019
  • Figure Global Dermatology OTC Medications Sales Market Share by Region in 2018
  • Table Global Dermatology OTC Medications Revenue by Region 2014-2019 (M USD)
  • Figure Global Dermatology OTC Medications Revenue Market Share by Region 2014-2019
  • Figure Global Dermatology OTC Medications Revenue Market Share by Region in 2018
  • Table Global Dermatology OTC Medications Sales by Manufacturer (2018-2019) (M Unit)
  • Table Global Dermatology OTC Medications Sales Share by Manufacturer (2018-2019)
  • Figure Global Dermatology OTC Medications Sales Share by Manufacturer in 2018
  • Table Dermatology OTC Medications Revenue by Manufacturer (2018-2019) (M USD)
  • Table Dermatology OTC Medications Revenue Share by Manufacturer (2018-2019)
  • Figure Dermatology OTC Medications Revenue Share by Manufacturer in 2018
  • Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table Key Manufacturers Dermatology OTC Medications Price (2018-2019) (USD/Unit)
  • Table Dermatology OTC Medications Manufacturers Manufacturing Base Distribution and Headquarters
  • Table Manufacturers Dermatology OTC Medications Product Type
  • Table Manufacturers Mergers & Acquisitions, Expansion Plans
  • Table Global Dermatology OTC Medications Sales by Type (2014-2019) (M Unit)
  • Table Global Dermatology OTC Medications Sales Share by Type (2014-2019)
  • Figure Global Dermatology OTC Medications Sales Market Share by Type (2014-2019)
  • Figure Global Dermatology OTC Medications Sales Market Share by Type in 2018
  • Table Global Dermatology OTC Medications Revenue by Type (2014-2019) (M USD)
  • Table Global Dermatology OTC Medications Revenue Share by Type (2014-2019)
  • Figure Global Dermatology OTC Medications Revenue Market Share by Type (2014-2019)
  • Figure Global Dermatology OTC Medications Revenue Market Share by Type in 2018
  • Table Dermatology OTC Medications Price by Type (2014-2019) (USD/Unit)
  • Table Global Dermatology OTC Medications Market Size Growth Rate by Application (2020-2025) (M Unit)
  • Table Global Dermatology OTC Medications Sales by Application (2014-2019) (M Unit)
  • Table Global Dermatology OTC Medications Sales Share by Application (2014-2019)
  • Figure Global Dermatology OTC Medications Market Share by Application (2014-2019)
  • Figure Global Dermatology OTC Medications Market Share by Application in 2018
  • Figure North America Dermatology OTC Medications Sales Growth Rate 2014-2019 (M Unit)
  • Figure North America Dermatology OTC Medications Revenue Growth Rate 2014-2019 (M USD)
  • Table North America Dermatology OTC Medications Sales by Country (2014-2019) (M Unit)
  • Table North America Dermatology OTC Medications Sales Market Share by Country (2014-2019)
  • Figure North America Dermatology OTC Medications Sales Market Share by Country in 2018
  • Table North America Dermatology OTC Medications Revenue by Country (2014-2019) (M USD)
  • Table North America Dermatology OTC Medications Revenue Market Share by Country (2014-2019)
  • Figure North America Dermatology OTC Medications Revenue Market Share by Country in 2018
  • Figure United States Dermatology OTC Medications Sales Growth Rate (2014-2019) (M Unit)
  • Figure United States Dermatology OTC Medications Revenue Growth Rate (2014-2019) (M USD)
  • Figure Canada Dermatology OTC Medications Sales Growth Rate (2014-2019) (M Unit)
  • Figure Canada Dermatology OTC Medications Revenue Growth Rate (2014-2019) (M USD)
  • Figure Mexico Dermatology OTC Medications Sales Growth Rate (2014-2019) (M Unit)
  • Figure Mexico Dermatology OTC Medications Revenue Growth Rate (2014-2019) (M USD)
  • Table North America Dermatology OTC Medications Sales by Type (2014-2019) (M Unit)
  • Table North America Dermatology OTC Medications Sales Market Share by Type (2014-2019)
  • Table North America Dermatology OTC Medications Sales by Application (2014-2019) (M Unit)
  • Table North America Dermatology OTC Medications Sales Market Share by Application (2014-2019)
  • Figure Europe Dermatology OTC Medications Sales Growth Rate 2014-2019 (M Unit)
  • Figure Europe Dermatology OTC Medications Revenue Growth Rate 2014-2019 (M USD)
  • Table Europe Dermatology OTC Medications Sales by Country (2014-2019) (M Unit)
  • Table Europe Dermatology OTC Medications Sales Market Share by Country (2014-2019)
  • Figure Europe Dermatology OTC Medications Sales Market Share by Country in 2018
  • Table Europe Dermatology OTC Medications Revenue by Country (2014-2019) (M USD)
  • Table Europe Dermatology OTC Medications Revenue Market Share by Country (2014-2019)
  • Figure Europe Dermatology OTC Medications Revenue Market Share by Country in 2018
  • Figure Germany Dermatology OTC Medications Sales Growth Rate (2014-2019) (M Unit)
  • Figure Germany Dermatology OTC Medications Revenue Growth Rate (2014-2019) (M USD)
  • Figure France Dermatology OTC Medications Sales Growth Rate (2014-2019) (M Unit)
  • Figure France Dermatology OTC Medications Revenue Growth Rate (2014-2019) (M USD)
  • Figure UK Dermatology OTC Medications Sales Growth Rate (2014-2019) (M Unit)
  • Figure UK Dermatology OTC Medications Revenue Growth Rate (2014-2019) (M USD)
  • Figure Italy Dermatology OTC Medications Sales Growth Rate (2014-2019) (M Unit)
  • Figure Italy Dermatology OTC Medications Revenue Growth Rate (2014-2019) (M USD)
  • Figure Russia Dermatology OTC Medications Sales Growth Rate (2014-2019) (M Unit)
  • Figure Russia Dermatology OTC Medications Revenue Growth Rate (2014-2019) (M USD)
  • Table Europe Dermatology OTC Medications Sales by Type (2014-2019) (M Unit)
  • Table Europe Dermatology OTC Medications Sales Market Share by Type (2014-2019)
  • Table Europe Dermatology OTC Medications Sales by Application (2014-2019) (M Unit)
  • Table Europe Dermatology OTC Medications Sales Market Share by Application (2014-2019)
  • Figure Asia Pacific Dermatology OTC Medications Sales Growth Rate 2014-2019 (M Unit)
  • Figure Asia Pacific Dermatology OTC Medications Revenue Growth Rate 2014-2019 (M USD)
  • Table Asia Pacific Dermatology OTC Medications Sales by Country (2014-2019) (M Unit)
  • Table Asia Pacific Dermatology OTC Medications Sales Market Share by Country (2014-2019)
  • Figure Asia Pacific Dermatology OTC Medications Sales Market Share by Country in 2018
  • Table Asia Pacific Dermatology OTC Medications Revenue by Country (2014-2019) (M USD)
  • Table Asia Pacific Dermatology OTC Medications Revenue Market Share by Country (2014-2019)
  • Figure Asia Pacific Dermatology OTC Medications Revenue Market Share by Country in 2018
  • Figure China Dermatology OTC Medications Sales Growth Rate (2014-2019) (M Unit)
  • Figure China Dermatology OTC Medications Revenue Growth Rate (2014-2019) (M USD)
  • Figure Japan Dermatology OTC Medications Sales Growth Rate (2014-2019) (M Unit)
  • Figure Japan Dermatology OTC Medications Revenue Growth Rate (2014-2019) (M USD)
  • Figure Korea Dermatology OTC Medications Sales Growth Rate (2014-2019) (M Unit)
  • Figure Korea Dermatology OTC Medications Revenue Growth Rate (2014-2019) (M USD)
  • Figure India Dermatology OTC Medications Sales Growth Rate (2014-2019) (M Unit)
  • Figure India Dermatology OTC Medications Revenue Growth Rate (2014-2019) (M USD)
  • Figure Australia Dermatology OTC Medications Sales Growth Rate (2014-2019) (M Unit)
  • Figure Australia Dermatology OTC Medications Revenue Growth Rate (2014-2019) (M USD)
  • Figure Southeast Asia Dermatology OTC Medications Sales Growth Rate (2014-2019) (M Unit)
  • Figure Southeast Asia Dermatology OTC Medications Revenue Growth Rate (2014-2019) (M USD)
  • Table Asia Pacific Dermatology OTC Medications Sales by Type (2014-2019) (M Unit)
  • Table Asia Pacific Dermatology OTC Medications Sales Market Share by Type (2014-2019)
  • Table Asia Pacific Dermatology OTC Medications Sales by Application (2014-2019) (M Unit)
  • Table Asia Pacific Dermatology OTC Medications Sales Market Share by Application (2014-2019)
  • Figure Central & South America Dermatology OTC Medications Sales Growth Rate 2014-2019 (M Unit)
  • Figure Central & South America Dermatology OTC Medications Revenue Growth Rate 2014-2019 (M USD)
  • Table Central & South America Dermatology OTC Medications Sales by Country (2014-2019) (M Unit)
  • Table Central & South America Dermatology OTC Medications Sales Market Share by Country (2014-2019)
  • Figure Central & South America Dermatology OTC Medications Sales Market Share by Country in 2018
  • Table Central & South America Dermatology OTC Medications Revenue by Country (2014-2019) (M USD)
  • Table Central & South America Dermatology OTC Medications Revenue Market Share by Country (2014-2019)
  • Figure Central & South America Dermatology OTC Medications Revenue Market Share by Country in 2018
  • Figure Brazil Dermatology OTC Medications Sales Growth Rate (2014-2019) (M Unit)
  • Figure Brazil Dermatology OTC Medications Revenue Growth Rate (2014-2019) (M USD)
  • Figure Argentina Dermatology OTC Medications Sales Growth Rate (2014-2019) (M Unit)
  • Figure Argentina Dermatology OTC Medications Revenue Growth Rate (2014-2019) (M USD)
  • Table Central & South America Dermatology OTC Medications Sales by Type (2014-2019) (M Unit)
  • Table Central & South America Dermatology OTC Medications Sales Market Share by Type (2014-2019)
  • Table Central & South America Dermatology OTC Medications Sales by Application (2014-2019) (M Unit)
  • Table Central & South America Dermatology OTC Medications Sales Market Share by Application (2014-2019)
  • Figure Middle East and Africa Dermatology OTC Medications Sales Growth Rate 2014-2019 (M Unit)
  • Figure Middle East and Africa Dermatology OTC Medications Revenue Growth Rate 2014-2019 (M USD)
  • Table Middle East and Africa Dermatology OTC Medications Sales by Country (2014-2019) (M Unit)
  • Table Middle East and Africa Dermatology OTC Medications Sales Market Share by Country (2014-2019)
  • Table Middle East and Africa Dermatology OTC Medications Revenue by Country (2014-2019) (M USD)
  • Table Middle East and Africa Dermatology OTC Medications Revenue Market Share by Country (2014-2019)
  • Figure Middle East and Africa Dermatology OTC Medications Revenue Market Share by Country in 2018
  • Figure Middle East Dermatology OTC Medications Sales Growth Rate (2014-2019) (M Unit)
  • Figure Middle East Dermatology OTC Medications Revenue Growth Rate (2014-2019) (M USD)
  • Figure Africa Dermatology OTC Medications Sales Growth Rate (2014-2019) (M Unit)
  • Figure Africa Dermatology OTC Medications Revenue Growth Rate (2014-2019) (M USD)
  • Table Middle East and Africa Dermatology OTC Medications Sales by Type (2014-2019) (M Unit)
  • Table Middle East and Africa Dermatology OTC Medications Sales Market Share by Type (2014-2019)
  • Table Middle East and Africa Dermatology OTC Medications Sales by Application (2014-2019) (M Unit)
  • Table Middle East and Africa Dermatology OTC Medications Sales Market Share by Application (2014-2019)
  • Table Bayer Company Profile
  • Figure Dermatology OTC Medications Product Picture of Bayer
  • Table Dermatology OTC Medications Sales (M Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Bayer 2018-2019
  • Table GSK Company Profile
  • Figure Dermatology OTC Medications Product Picture of GSK
  • Table Dermatology OTC Medications Sales (M Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of GSK 2018-2019
  • Table Teva Company Profile
  • Figure Dermatology OTC Medications Product Picture of Teva
  • Table Dermatology OTC Medications Sales (M Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Teva 2018-2019
  • Table Johnson & Johnson Company Profile
  • Figure Dermatology OTC Medications Product Picture of Johnson & Johnson
  • Table Dermatology OTC Medications Sales (M Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Johnson & Johnson 2018-2019
  • Table Novartis Company Profile
  • Figure Dermatology OTC Medications Product Picture of Novartis
  • Table Dermatology OTC Medications Sales (M Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Novartis 2018-2019
  • Table Mylan Company Profile
  • Figure Dermatology OTC Medications Product Picture of Mylan
  • Table Dermatology OTC Medications Sales (M Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Mylan 2018-2019
  • Table Sun Pharmaceutical Company Profile
  • Figure Dermatology OTC Medications Product Picture of Sun Pharmaceutical
  • Table Dermatology OTC Medications Sales (M Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Sun Pharmaceutical 2018-2019
  • Table Aurobindo Company Profile
  • Figure Dermatology OTC Medications Product Picture of Aurobindo
  • Table Dermatology OTC Medications Sales (M Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Aurobindo 2018-2019
  • Table Galderma Company Profile
  • Figure Dermatology OTC Medications Product Picture of Galderma
  • Table Dermatology OTC Medications Sales (M Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Galderma 2018-2019
  • Table CR SANJIU Company Profile
  • Figure Dermatology OTC Medications Product Picture of CR SANJIU
  • Table Dermatology OTC Medications Sales (M Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of CR SANJIU 2018-2019
  • Table Dr. Reddy's Company Profile
  • Figure Dermatology OTC Medications Product Picture of Dr. Reddy's
  • Table Dermatology OTC Medications Sales (M Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Dr. Reddy's 2018-2019
  • Table Lupin Company Profile
  • Figure Dermatology OTC Medications Product Picture of Lupin
  • Table Dermatology OTC Medications Sales (M Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Lupin 2018-2019
  • Table Bausch Health Company Profile
  • Figure Dermatology OTC Medications Product Picture of Bausch Health
  • Table Dermatology OTC Medications Sales (M Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Bausch Health 2018-2019
  • Table Cipla Company Profile
  • Figure Dermatology OTC Medications Product Picture of Cipla
  • Table Dermatology OTC Medications Sales (M Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Cipla 2018-2019
  • Table Qilu Pharmaceutical Company Profile
  • Figure Dermatology OTC Medications Product Picture of Qilu Pharmaceutical
  • Table Dermatology OTC Medications Sales (M Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Qilu Pharmaceutical 2018-2019
  • Table Almirall Company Profile
  • Figure Dermatology OTC Medications Product Picture of Almirall
  • Table Dermatology OTC Medications Sales (M Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Almirall 2018-2019
  • Table Lingrui Company Profile
  • Figure Dermatology OTC Medications Product Picture of Lingrui
  • Table Dermatology OTC Medications Sales (M Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Lingrui 2018-2019
  • Table Global Dermatology OTC Medications Sales Forecast by Region 2020-2025 (M Unit)
  • Table Global Dermatology OTC Medications Sales Market Share Forecast by Region 2020-2025
  • Table Global Dermatology OTC Medications Revenue Forecast by Region 2020-2025 (M USD)
  • Table Global Dermatology OTC Medications Revenue Market Share Forecast by Region 2020-2025
  • Table Global Dermatology OTC Medications Sales Forecast by Type (2020-2025) (M Unit)
  • Table Global Dermatology OTC Medications Sales Market Share Forecast by Type (2020-2025)
  • Table Global Dermatology OTC Medications Revenue Forecast by Type (2020-2025) (M USD)
  • Table Global Dermatology OTC Medications Revenue Market Share Forecast by Type (2020-2025)
  • Table Global Dermatology OTC Medications Sales Forecast by Application (2020-2025) (M Unit)
  • Table Global Dermatology OTC Medications Sales Market Share Forecast by Application (2020-2025)
  • Figure North America Dermatology OTC Medications Sales Growth Rate Forecast (2020-2025) (M Unit)
  • Figure North America Dermatology OTC Medications Revenue Growth Rate Forecast (2020-2025) (M USD)
  • Figure Europe Dermatology OTC Medications Sales Growth Rate Forecast (2020-2025) (M Unit)
  • Figure Europe Dermatology OTC Medications Revenue Growth Rate Forecast (2020-2025) (M USD)
  • Figure Asia Pacific Dermatology OTC Medications Sales Growth Rate Forecast (2020-2025) (M Unit)
  • Figure Asia Pacific Dermatology OTC Medications Revenue Growth Rate Forecast (2020-2025) (M USD)
  • Figure Central & South America Dermatology OTC Medications Sales Growth Rate Forecast (2020-2025) (M Unit)
  • Figure Central & South America Dermatology OTC Medications Revenue Growth Rate Forecast (2020-2025) (M USD)
  • Figure Middle East and Africa Dermatology OTC Medications Sales Growth Rate Forecast (2020-2025) (M Unit)
  • Figure Middle East and Africa Dermatology OTC Medications Revenue Growth Rate Forecast (2020-2025) (M USD)
  • Table Key Opportunities and Drivers: Impact Analysis (2020-2025)
  • Table Key Trends for Dermatology OTC Medications Markets & Products
  • Table Market Risks
  • Figure Porter's Five Forces Analysis
  • Figure Dermatology OTC Medications Value Chain
  • Table Dermatology OTC Medications Customers List
  • Figure Channels of Distribution
  • Table Dermatology OTC Medications Distributors List
  • Figure Distributors Profiles
  • Table Research Programs/Design for This Report
  • Figure Bottom-up and Top-down Approaches for This Report
  • Figure Data Triangulation
  • Figure Key Executives Interviewed
  • Table Key Data Information from Secondary Sources
  • Table Key Data Information from Primary Sources
Back to Top